Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CytomX Therapeutics (CTMX) Interest Coverage Ratio (2016 - 2017)

Historic Interest Coverage Ratio for CytomX Therapeutics (CTMX) over the last 4 years, with Q1 2017 value amounting to 41.82.

  • CytomX Therapeutics' Interest Coverage Ratio rose 878.21% to 41.82 in Q1 2017 from the same period last year, while for Dec 2017 it was 224.56, marking a year-over-year decrease of 53652.35%. This contributed to the annual value of 35.28 for FY2016, which is 8402.85% down from last year.
  • As of Q1 2017, CytomX Therapeutics' Interest Coverage Ratio stood at 41.82, which was up 878.21% from 36.58 recorded in Q4 2016.
  • Over the past 5 years, CytomX Therapeutics' Interest Coverage Ratio peaked at 13.58 during Q2 2015, and registered a low of 45.84 during Q1 2016.
  • Moreover, its 4-year median value for Interest Coverage Ratio was 30.66 (2016), whereas its average is 30.84.
  • Per our database at Business Quant, CytomX Therapeutics' Interest Coverage Ratio soared by 4698.86% in 2015 and then tumbled by 12573.52% in 2016.
  • Over the past 4 years, CytomX Therapeutics' Interest Coverage Ratio (Quarter) stood at 42.74 in 2014, then rose by 28.3% to 30.65 in 2015, then dropped by 19.35% to 36.58 in 2016, then fell by 14.31% to 41.82 in 2017.
  • Its Interest Coverage Ratio was 41.82 in Q1 2017, compared to 36.58 in Q4 2016 and 30.95 in Q3 2016.